Who owns Affimed Therapeutics B V?
- CUSIP Number: n01045108
Tip: Access positions for across all investors
Analyze quarterly positions in Affimed Therapeutics B V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Affimed Therapeutics B V stock
Who bought or sold Affimed Therapeutics B V this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| IFP Advisors | 1.2k | $718.980000 | 0% | Dec 2023 |
|
| Cape Investment Advisory | 100.00 | $63.000000 | 0% | Dec 2023 |
|
Who sold out of Affimed Therapeutics B V?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ridgeback Capital Investments | Dec 2023 | 15M | $9.3M |
| 683 Capital Management | Dec 2023 | 7.0M | $4.4M |
| NEA Management Company | Dec 2023 | 4.4M | $2.8M |
| Point72 Asset Management | Dec 2023 | 4.2M | $2.6M |
| Millennium Management | Dec 2023 | 2.0M | $1.3M |
| FMR | Sep 2023 | 1.4M | $692k |
| Vanguard Group | Dec 2023 | 1.4M | $881k |
| BlackRock | Sep 2023 | 1.2M | $550k |
| Verition Fund Management | Sep 2023 | 1.1M | $520k |
| Morgan Stanley | Sep 2023 | 1.1M | $502k |
| Two Sigma Advisers | Dec 2023 | 690k | $431k |
| Kennedy Capital Management | Dec 2023 | 632k | $395k |
| Two Sigma Investments | Dec 2023 | 632k | $395k |
| Marshall Wace | Dec 2023 | 607k | $383k |
| Bnp Paribas Arbitrage, Snc | Dec 2023 | 572k | $358k |
| Intellectus Partners | Dec 2023 | 410k | $257k |
| Alyeska Investment Group | Dec 2023 | 350k | $219k |
| Standard Life Aberdeen | Dec 2023 | 209k | $130k |
| Commonwealth Equity Services | Dec 2023 | 205k | $128k |
| Ewa | Dec 2023 | 143k | $78k |
| Wells Fargo & Company | Dec 2023 | 140k | $87k |
| Geode Capital Management | Sep 2023 | 136k | $65k |
| Acadian Asset Management | Sep 2023 | 110k | $51k |
| Brown Advisory Holdings Incorporated | Dec 2023 | 90k | $56k |
| Two Sigma Securities | Dec 2023 | 84k | $52k |
| Squarepoint Ops | Dec 2023 | 80k | $50k |
| Barclays | Dec 2023 | 75k | $48k |
| Citadel Advisors | Dec 2023 | 75k | $47k |
| Harbor Investment Advisory | Dec 2023 | 59k | $37k |
| Jane Street | Dec 2023 | 57k | $36k |
| LMR Partners | Dec 2023 | 51k | $32k |
| Advisor Group Holdings | Dec 2023 | 42k | $26k |
| LPL Financial | Sep 2023 | 41k | $20k |
| Tower Research Capital | Sep 2023 | 41k | $20k |
| Cubist Systematic Strategies | Dec 2023 | 40k | $25k |
| Royal Bank of Canada | Dec 2023 | 38k | $0 |
| Goldman Sachs Group | Dec 2023 | 27k | $17k |
| Us Bancorp | Dec 2023 | 24k | $15k |
| Qube Research & Technologies | Sep 2023 | 20k | $9.7k |
| Susquehanna International | Sep 2023 | 19k | $8.9k |
| Cetera Investment Advisers | Sep 2023 | 15k | $7.2k |
| Clear Harbor Asset Management | Dec 2023 | 15k | $8.2k |
| Bank Of Montreal | Dec 2023 | 14k | $8.5k |
| Dimensional Fund Advisors | Dec 2023 | 13k | $8.3k |
| HighTower Advisors | Dec 2023 | 11k | $7.0k |
| A. Montag and Associates | Dec 2023 | 10k | $6.3k |
| Pnc Financial Services | Dec 2023 | 6.0k | $3.8k |
| Group One Trading | Sep 2023 | 4.8k | $2.3k |
| Point72 Asia | Dec 2023 | 4.2k | $2.6k |
| Bank of America Corporation | Dec 2023 | 1.8k | $902.000000 |
| Newbridge Financial Services Group | Dec 2023 | 1.5k | $937.050000 |
| Wetzel Investment Advisors | Dec 2023 | 1.0k | $1.0k |
| Simplex Trading | Dec 2023 | 900.00 | $0 |
| Ronald Blue Trust | Dec 2023 | 335.00 | $0 |
| Jpmorgan Chase & Co | Dec 2023 | 199.00 | $123.996900 |
| Parkside Financial Bank & Trust | Dec 2023 | 150.00 | $94.005000 |
| Citigroup | Dec 2023 | 122.00 | $77.640800 |